Nutra Pharma Corp (NPHC) Shares Outstanding (2011 - 2026)

Nutra Pharma has disclosed Shares Outstanding (Entity) across 16 years of filings, most recently posting $7.2 billion for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 0.85% year-over-year to $7.2 billion; the TTM figure through Jun 2026 stood at $7.2 billion (up 0.85% YoY), while the FY2025 annual figure was $7.1 billion, changed 0.0% from the prior year.
• Shares Outstanding (Entity) came in at $7.2 billion for Q2 2026 at Nutra Pharma, roughly flat from $7.2 billion in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $7.6 billion in Q3 2022 to a low of $7.0 billion in Q4 2022.
• Average Shares Outstanding (Entity) over 5 years is $7.2 billion, with a median of $7.1 billion recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) grew 4.39% in 2022 and fell 7.21% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $7.0 billion in 2022, then climbed by 0.36% to $7.1 billion in 2023, then advanced by 0.5% to $7.1 billion in 2024, then changed by 0.0% to $7.1 billion in 2025, then advanced by 0.85% to $7.2 billion in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $7.2 billion in Q2 2026, $7.2 billion in Q1 2026, and $7.1 billion in Q4 2025.